ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression-0

S was normalized to the geometric mean of the two reference genes PPIA and TBP. For most cases mRNA levels of the renal cell cancers laid above those of the normal tissue standard.<p><b>Copyright information:</b></p><p>Taken from "ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression"</p><p>http://www.biomedcentral.com/1471-2407/8/179</p><p>BMC Cancer 2008;8():179-179.</p><p>Published online 26 Jun 2008</p><p>PMCID:PMC2442841.</p><p></p

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression-1

Apillary () and chromophobe () renal cell carcinoma with strong ADAM9 expression. Normal renal tissue with weak () and strong () ADAM9 expression.<p><b>Copyright information:</b></p><p>Taken from "ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression"</p><p>http://www.biomedcentral.com/1471-2407/8/179</p><p>BMC Cancer 2008;8():179-179.</p><p>Published online 26 Jun 2008</p><p>PMCID:PMC2442841.</p><p></p

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression-3

S was normalized to the geometric mean of the two reference genes PPIA and TBP. For most cases mRNA levels of the renal cell cancers laid above those of the normal tissue standard.<p><b>Copyright information:</b></p><p>Taken from "ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression"</p><p>http://www.biomedcentral.com/1471-2407/8/179</p><p>BMC Cancer 2008;8():179-179.</p><p>Published online 26 Jun 2008</p><p>PMCID:PMC2442841.</p><p></p

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression-2

Old line) revealed significantly shortened patient survival times if compared to those with low ADAM9 expression (dotted line).<p><b>Copyright information:</b></p><p>Taken from "ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression"</p><p>http://www.biomedcentral.com/1471-2407/8/179</p><p>BMC Cancer 2008;8():179-179.</p><p>Published online 26 Jun 2008</p><p>PMCID:PMC2442841.</p><p></p